- Philstar.com
- The Philippine Star
- Pilipino Star Ngayon
- The Freeman
- Pang-Masa
- Banat
- Interaksyon
- Coupons
Array ( [results] => Array ( [0] => Array ( [ArticleID] => 1290305 [Title] => FDA approves Pharmacyclics, J&J drug for new use in treating rare bone marrow leukemia [Summary] =>The Food and Drug Administration on Wednesday approved a cancer drug from Pharmacyclics and Johnson & Johnson for a new use against a rare blood and bone marrow disease.
[DatePublished] => 2014-02-14 00:23:17 [ColumnID] => 0 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => http://premium.mofusecdn.com/80f2c8ee7542896ed15e3296a6cd0df2/cache/post-images/d9a6eed5345ed108fbde6630bebb911d.570.0.0.jpg ) [1] => Array ( [ArticleID] => 1257009 [Title] => FDA approves new drug for rare blood cancer [Summary] =>The Food and Drug Administration on Wednesday approved a new drug from Pharmacyclics and Janssen Biotech Inc. to treat a rare and aggressive form of blood cancer.
[DatePublished] => 2013-11-15 03:26:01 [ColumnID] => 0 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => http://premium.mofusecdn.com/80f2c8ee7542896ed15e3296a6cd0df2/cache/post-images/d9a6eed5345ed108fbde6630bebb911d.570.0.0.jpg ) ) )
IMBRUVICA
Array ( [results] => Array ( [0] => Array ( [ArticleID] => 1290305 [Title] => FDA approves Pharmacyclics, J&J drug for new use in treating rare bone marrow leukemia [Summary] =>The Food and Drug Administration on Wednesday approved a cancer drug from Pharmacyclics and Johnson & Johnson for a new use against a rare blood and bone marrow disease.
[DatePublished] => 2014-02-14 00:23:17 [ColumnID] => 0 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => http://premium.mofusecdn.com/80f2c8ee7542896ed15e3296a6cd0df2/cache/post-images/d9a6eed5345ed108fbde6630bebb911d.570.0.0.jpg ) [1] => Array ( [ArticleID] => 1257009 [Title] => FDA approves new drug for rare blood cancer [Summary] =>The Food and Drug Administration on Wednesday approved a new drug from Pharmacyclics and Janssen Biotech Inc. to treat a rare and aggressive form of blood cancer.
[DatePublished] => 2013-11-15 03:26:01 [ColumnID] => 0 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => http://premium.mofusecdn.com/80f2c8ee7542896ed15e3296a6cd0df2/cache/post-images/d9a6eed5345ed108fbde6630bebb911d.570.0.0.jpg ) ) )
abtest
EZ2/LVM - 4 13
SUERTRES - 6 6 6
6D Lotto - 7 9 6 4 0 1
6/42 Lotto - 38 18 17 41 40 8
P27,484,056.00
6/49 Super Lotto - 21 8 12 14 36 3
P19,861,578.00
6/58 Ultra Lotto - 18 37 17 40 34 57
P244,874,068.00
- 12:00 am